It’s hard for practicing oncologists to stay on top of the latest clinical data, but good partnerships and clinical decision ...
Biotech Nuvalent unveiled updates on two experimental cancer medicines over the weekend. Analysts say each could be the best ...
The National Comprehensive Cancer Network Policy Summit emphasized the importance of integrating diversity, equity, and ...
Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the ...
Bispecific antibodies and anti-TIGIT therapies both appear to be writing comeback stories as cancer experts head to Barcelona for the 2024 European Society for Medical Oncology Congress. Radioligand ...
Pfizer Inc. (NYSE: PFE) continues to showcase potential practice-changing research and next-generation candidates across its ...
Westside Current on MSN4d
Innovent Delivers Oral Presentations on Clinical Data of IBI354 (HER2 Monoclonal Antibody-Camptothecin Derivative Conjugate) in Advanced Ovarian Cancer, Breast Cancer and Other ...SAN FRANCISCO and SUZHOU, China, Sept. 17, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
The Medicaid Cancer Foundation (MCF), on behalf of the International Gynecologic Cancer Society (IGCS), has honored its CEO, ...
At WCLC, five-year survival data to be presented on Libtayo (PD-1 inhibitor) first-line monotherapy in advanced non-small cell lung cancerAt ...
Analyst Judah Frommer from Morgan Stanley maintained a Buy rating on Mural Oncology Plc (MURA – Research Report) and keeping the price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback